Therapeutic antibodies and infectious diseases, Tours, France, November 20−22, 2012

The high-affinity human IgG receptor Fc RI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy

(2013) D. A. Mancardi et al.   BLOOD

An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission

(2013) Alexander W. Tarr et al.   HEPATOLOGY

Properties of mouse and human IgG receptors and their contribution to disease models

(2012) P. Bruhns   BLOOD

Outbreak of Shiga Toxin-Producing Escherichia coli O104:H4 Associated With Organic Fenugreek Sprouts, France, June 2011

(2012) L. A. King et al.   CLINICAL INFECTIOUS DISEASES

Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa

(2012) Bruno François et al.   CRITICAL CARE MEDICINE

Universal vaccine against influenza virus: Linking TLR signaling to anti-viral protection

(2012) Nicole Schmitz et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination

(2012) Muhammad N. Zahid et al.   HEPATOLOGY

Targeting Pan-Resistant Bacteria With Antibodies to a Broadly Conserved Surface Polysaccharide Expressed During Infection

(2012) David Skurnik et al.   JOURNAL OF INFECTIOUS DISEASES

Passive immunity in the prevention of rabies

(2012) Leonard Both et al.   LANCET INFECTIOUS DISEASES

HIV therapy by a combination of broadly neutralizing antibodies in humanized mice

(2012) Florian Klein et al.   NATURE

Staphylococcus aureus Isolates Encode Variant Staphylococcal Enterotoxin B Proteins That Are Diverse in Superantigenicity and Lethality

(2012) Petra L. Kohler et al.   PLoS One

Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease

(2012) J. M. Dye et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo

(2012) B. Moldt et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

(2012) J. Menne et al.   BMJ-British Medical Journal

Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY-1

(2011) Carmen Bozic et al.   ANNALS OF NEUROLOGY

A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection

(2011) Marcella Visentini et al.   AUTOIMMUNITY REVIEWS

Consistent manufacturing and quality control of a highly complex recombinant polyclonal antibody product for human therapeutic use

(2011) Torben P. Frandsen et al.   BIOTECHNOLOGY AND BIOENGINEERING

Human Fc RIIA induces anaphylactic and allergic reactions

(2011) F. Jonsson et al.   BLOOD

Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia

(2011) Q. Lu et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Broad neutralization coverage of HIV by multiple highly potent antibodies

(2011) Laura M. Walker et al.   NATURE

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy

(2011) P. Vermersch et al.   NEUROLOGY

A Neutralizing Human Monoclonal Antibody Protects African Green Monkeys from Hendra Virus Challenge

(2011) K. N. Bossart et al.   Science Translational Medicine

A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

(2010) F. Vincenti et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry

(2010) D. Salmon-Ceron et al.   ANNALS OF THE RHEUMATIC DISEASES

Preclinical In Vitro and In Vivo Characterization of the Fully Human Monoclonal IgM Antibody KBPA101 Specific for Pseudomonas aeruginosa Serotype IATS-O11

(2010) M. P. Horn et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease

(2010) A. Petrarca et al.   BLOOD

Monoclonal Anti-Claudin 1 Antibodies Prevent Hepatitis C Virus Infection of Primary Human Hepatocytes

(2010) Isabel Fofana et al.   GASTROENTEROLOGY

Long-Lasting Protective Antiviral Immunity Induced by Passive Immunotherapies Requires both Neutralizing and Effector Functions of the Administered Monoclonal Antibody

(2010) R. Nasser et al.   JOURNAL OF VIROLOGY

A Crucial Role for Infected-Cell/Antibody Immune Complexes in the Enhancement of Endogenous Antiviral Immunity by Short Passive Immunotherapy

(2010) Henri-Alexandre Michaud et al.   PLoS Pathogens

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

(2009) W. G. Dixon et al.   ANNALS OF THE RHEUMATIC DISEASES

Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-Claudin-1 associations

(2009) Sophie E. Krieger et al.   HEPATOLOGY

Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target

(2009) L. M. Walker et al.   SCIENCE

Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against Influenza A M2 protein

(2009) Roger R Beerli et al.   Virology Journal

A Neutralizing Human Monoclonal Antibody Protects against Lethal Disease in a New Ferret Model of Acute Nipah Virus Infection

(2009) Katharine N. Bossart et al.   PLoS Pathogens

Specificity and affinity of human Fc  receptors and their polymorphic variants for human IgG subclasses

(2008) P. Bruhns et al.   BLOOD

An Engineered Human Antibody Fab Fragment Specific for Pseudomonas aeruginosa PcrV Antigen Has Potent Antibacterial Activity

(2008) M. Baer et al.   INFECTION AND IMMUNITY

Improvement of an Antibody Neutralizing the Anthrax Toxin by Simultaneous Mutagenesis of Its Six Hypervariable Loops

(2008) Emmanuelle Laffly et al.   JOURNAL OF MOLECULAR BIOLOGY

Isolation of human monoclonal antibodies by mammalian cell display

(2008) R. R. Beerli et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

First administration to humans of a monoclonal antibody cocktail against rabies virus: Safety, tolerability, and neutralizing activity

(2008) A.B.H. Bakker et al.   VACCINE